Response to Radioiodine Therapy for Thyrotoxicosis: Disparate Outcomes for an Indigenous Population
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2016, 1-6
Abstract
Despite 70 years of experience treating thyrotoxic patients with radioiodine not all patients are successfully treated by a single dose. Multiple factors predicting radioiodine efficacy have been reported. The aim of this study was to assess whether ethnicity was associated with radioiodine response. A retrospective review was performed of patients who received radioiodine therapy for thyrotoxicosis from 1 January 2008 to 31 December 2010 and had follow-up available of a minimum of 12 months. 224 patients were included, 82.4% female, and 63.7% had Graves’s disease. Radioiodine failed in 21.5% of patients overall, with a higher failure rate in the indigenous population (35.2%). When controlling for other influencing factors by logistic regression, there continued to be an increased risk for the indigenous group (OR 2.82) and those treated with antithyroid drugs following radioiodine (OR 2.04). Younger age was also associated with an increased risk of failing radioiodine therapy (OR 0.97 for each year of age). Cure rates following radioiodine were lower for indigenes independent of factors known to affect radioiodine outcome. This is the first report demonstrating ethnicity as a possible independent variable for radioiodine efficacy. Further work is needed to investigate the cause of this difference.Keywords
Funding Information
- Royal Australasian College of Physicians (14/074)
- Health Research Council of New Zealand (14/074)
This publication has 34 references indexed in Scilit:
- Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysisThyroid®, 2009
- Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidismClinical Endocrinology, 2008
- Increased cancer incidence after radioiodine treatment for hyperthyroidismCancer, 2007
- Long‐term follow‐up study of radioiodine treatment of hyperthyroidismClinical Endocrinology, 2004
- Ultrasonographic Thyroid Volume as a Reliable Prognostic Index of Radioiodine-131 Treatment Outcome in Graves’ Disease HyperthyroidismHormone and Metabolic Research, 2003
- High Dose 131I Therapy for the Treatment of Hyperthyroidism Caused by Graves' DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2002
- The Effect of Methimazole on Cure Rates After Radioiodine Treatment for Graves' Hyperthyroidism: A Randomized Clinical TrialThyroid®, 2002
- Radioiodine Treatment of Hyperthyroidism--Prognostic Factors for OutcomeThe Journal of Clinical Endocrinology & Metabolism, 2001
- The Effect of Methimazole Pretreatment on the Efficacy of Radioactive Iodine Therapy in Graves' Hyperthyroidism: One-Year Follow-Up of a Prospective, Randomized StudyThe Journal of Clinical Endocrinology & Metabolism, 2001
- Age and Gender Predict the Outcome of Treatment for Graves' HyperthyroidismThe Journal of Clinical Endocrinology & Metabolism, 2000